Pharmaceutical Products for CDER Research Studies - IDIQ

The contract is an Indefinite-Delivery/Indefinite-Quantity (IDIQ) vehicle for the procurement of pharmaceutical products to support the U.S. FDA’s Center for Drug Evaluation and Research (CDER) in research initiatives focused on generic drug equivalence and public health. The solicitation number is 75F40126Q132721, issued by the FDA Office of Acquisitions & Grants Services under the Department of Health and Human Services, with a response deadline of May 15, 2026. The base contract spans five one-year ordering periods from September 1, 2026, through August 31, 2031, with delivery orders extendable up to one year beyond each period. The total maximum ceiling for all orders over the life of the contract is $4,000,000, including shipping, with a guaranteed minimum funding obligation of $25,000. Deliveries are required to FDA offices, domestic external research collaborators, and international sites, with strict delivery timelines: seven business days for domestic locations and fourteen for international, including provisions for emergency overnight delivery. The contract mandates FOB Destination terms, meaning the contractor bears all shipping costs and risks until delivery. Offerors must submit pricing through Attachment 1, including unit pricing across the five ordering periods, and demonstrate technical capability by meeting or exceeding product specifications. Past performance is evaluated based on documented experience with brand and generic pharmaceuticals within the last three years, requiring details on period of performance, scope, role, dollar value, and client contacts. Price is a secondary factor in award, only acting as a tiebreaker if technical and past performance are essentially equal, and the Government will use a best value trade-off, not a lowest price technically acceptable approach. A small business subcontracting plan is required for non-small businesses and will be evaluated as acceptable or unacceptable; failure to submit renders the offer ineligible. Compliance with Section 508 accessibility standards for information and communication technology is mandatory, requiring submission of an HHS Accessibility Conformance Report using VPAT, with remediation of non-compliant items at the contractor’s expense. All invoices must be submitted electronically through the Treasury’s Invoice Processing Platform, and SAM registration is required throughout the contract term. The contracting officer is Nick Sartain, and the contract incorporates numerous FAR clauses with deviations, including restrictions on subcontractor sales, whistleblower rights, prohibitions on confidentiality agreements, trade agreements, payment by electronic funds